Punicalagin mitigates benzo[α]pyrene induced epithelial-mesenchymal transition and migration in triple‑negative breast cancer cells
摘要
Breast cancer is one of the most prevalent cancers among women, often attributed to genetic mutations, hormonal imbalances, and lifestyle factors. The compound benzo[α]pyrene (B[α]P) is commonly found in emissions and fumes from industrial processes and cigarette smoke. Punicalagin (PCG), a polyphenolic compound in pomegranates, is reported to have antioxidant, anti-inflammatory, anti-cancer, and antiviral activities. In this study, we aimed to determine whether B[α]P induced toxicity in breast cancer cells and to assess the role of PCG in mitigating this toxicity. The water-soluble tetrazolium salt (WST) assay showed that exposure of MDA-MB-231 and MCF-7 cells to B[α]P at 1–32 µM decreased their viability. B[α]P also resulted in the decrease of the mitochondrial membrane potential in both cell lines. The change in mitochondrial reactive oxygen species levels was confirmed using MitoSOX™ staining of MDA-MB-231 and MCF-7 cells, and the level of red fluorescence increased upon exposure to B[α]P compared to the control group. In the scratch wound healing and transwell migration assays, B[α]P induced migration of MDA-MB-231 cells, which was mitigated by PCG. Furthermore, there was an increase in the N-cadherin expression and a decrease in the E-cadherin expression on exposure to B[α]P. However, PCG reversed this trend. Our findings suggest that PCG mitigates B[α]P-induced mitochondrial dysfunction, oxidative stress, and epithelial-mesenchymal transition, thereby reversing B[α]P’s pro-tumorigenic effects in breast cancer cells.
Graphical Abstract